Cargando…
Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes
BACKGROUND: As a complex group of malignancies, head and neck squamous cell carcinoma (HNSC) is one of the leading causes of cancer mortality. This study aims to establish a reliable clinical classification and gene signature for HNSC prognostic prediction and precision treatments. METHODS: A consen...
Autores principales: | Xu, Chengbo, Xu, Hongfang, Liu, Baimei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668860/ https://www.ncbi.nlm.nih.gov/pubmed/38025757 http://dx.doi.org/10.7717/peerj.16364 |
Ejemplares similares
-
Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma
por: Li, Zhexuan, et al.
Publicado: (2021) -
HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
por: Chen, Yan, et al.
Publicado: (2023) -
Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020) -
Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020) -
Identification of novel subtypes based on ssGSEA in immune‐related prognostic signature for tongue squamous cell carcinoma
por: Jin, Yi, et al.
Publicado: (2021)